We are pleased to announce that Argus Partners advised Surya Hospitals and its promoter Dr. Bhupendra Avasthi, on a transaction comprising a primary investment by Novo Holdings’ (a leading global investor in healthcare and life sciences) in Surya Hospitals, and a secondary sale of shares held by Sealink Capital Partners (“SCP”) in Surya Hospitals to Novo Holdings, pursuant to which SCP has fully exited its investment in Surya Hospitals.

Surya Hospitals is the largest private women’s and children’s specialty hospital chain in Western India. Established in 1984, the group operates specialty hospitals across Mumbai, Pune, and Jaipur, offering comprehensive services in obstetrics and gynaecology, neonatal and paediatric intensive care, fertility, and paediatric sub-specialties. Surya Hospitals is widely recognised for its clinical excellence, strong patient outcomes, and highly regarded medical teams.

Novo Holdings’ investment will support Surya Hospitals’ next phase of growth, including the expansion of its footprint across Western India, continued buildup of the clinical infrastructure, and the strengthening of its specialist medical teams. The partnership brings together Surya’s well-established clinical leadership with Novo Holdings’ long-term, engaged ownership approach and connectivity across a global healthcare ecosystem.

The deal team at Argus Partners consisted of Krishnava Dutt (Managing Partner), Abhinav Bhalaik, Aayush Kumar (Partners) and Paridhi Rastogi, Anoushka Goel (Associates).

The due diligence team at Argus Partners consisted of Aayush Kumar (Partner) and Paridhi Rastogi, Vishakha Somani, Anoushka Goel (Associates).